All Stories

  1. Balancing Risk and Learning Opportunities in Corporate Venture Capital Investments: Evidence from the Biopharmaceutical Industry

    Article • Entrepreneurship Research Journal, January 2015, De Gruyter

    Prof. Francesco Baldi